Browse by author
Lookup NU author(s): Professor Roderick Skinner
Full text for this publication is not currently held within this repository. Alternative links are provided below where available.
Existing standards for screening and management of late effects occurring in children who have undergone hematopoietic cell transplantation (HCT) include recommendations from pediatric cancer networks and consensus guidelines from adult-oriented transplantation societies applicable to all HCT recipients. Although these approaches have significant merit, they are not pediatric HCT-focused, and they do not address post-HCT challenges faced by children with complex nonmalignant disorders. In this article we discuss the strengths and weaknesses of current published recommendations and conclude that pediatric-specific guidelines for post-HCT screening and management would be beneficial to the long-term health of these patients and would promote late effects research in this field. Our panel of late effects experts also provides recommendations for follow-up and therapy of selected post-HCTorgan and endocrine complications in pediatric patients. Biol Mood Marrow Transplant 18: 334-347 (2012) (C) 2012 American Society for Blood and Marrow Transplantation
Author(s): Pulsipher MA, Skinner R, McDonald GB, Hingorani S, Armenian SH, Cooke KR, Gracia C, Petryk A, Bhatia S, Bunin N, Nieder ML, Dvorak CC, Sung LL, Sanders JE, Kurtzberg J, Baker KS
Publication type: Article
Publication status: Published
Journal: Biology of Blood and Marrow Transplantation
Year: 2012
Volume: 18
Issue: 3
Pages: 334-347
Print publication date: 01/03/2012
Online publication date: 13/01/2012
Acceptance date: 11/01/2012
ISSN (print): 1083-8791
ISSN (electronic): 1523-6536
Publisher: Elsevier
URL: http://dx.doi.org/10.1016/j.bbmt.2012.01.003
DOI: 10.1016/j.bbmt.2012.01.003
Altmetrics provided by Altmetric